Johnson & Johnson (JNJ)

NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals · US

$269.99
0.09% today
Pharma MajorsDividend Aristocrats

Should you buy JNJ?

Neutral

Johnson & Johnson is roughly flat today (-0.09%). Recent news mentions geopolitical tensions, which may be contributing to the decline. JNJ is trading near its 52-week high ($281.07), showing strong long-term momentum.

  • News: geopolitical tensions
  • Near 52-week high

This is educational analysis, not investment advice. Past performance doesn't predict future results.

Market Cap

$650.65B

52W High

$272.11

52W Low

$267.20

Industry

Pharmaceuticals

Understand the fundamentals

Plain-English rules of thumb for beginners — tap the  to learn each one. Not investment advice.

P/E — Price / Earnings
30.9xTake a closer look

How many years of profit you're paying for. Lower can mean cheaper — but a very low number can also signal trouble.

Pricey — the market expects high growth.

P/B — Price / Book
7.3xTake a closer look

Price vs the company's net assets (book value). Under 1x means it trades below what it owns on paper.

High — you're paying a big premium over assets.

ROE — Return on Equity
25.7%Looks healthy

How efficiently the company turns shareholders' money into profit. Higher is better.

Strong — uses your capital efficiently.

Net Margin
21.5%Looks healthy

Of every $100 in sales, how much becomes actual profit. Higher = more profitable business.

Highly profitable per dollar of sales.

Dividend Yield
3.12%Info

Annual cash the company pays you, as a % of the share price. Not better or worse — just a different kind of return.

Pays you cash while you hold.

These signals are simple, sector-agnostic rules of thumb (a “good” P/E for a bank differs from a tech firm). Use them to learn what to look at — not as buy/sell calls.

Recent news

Think you can trade JNJ better?

Practice with real prices and $10,000 of paper money. An AI coach grades every trade so you learn before risking real cash.

Start free — no signup pressure